Joshua Grill
Joshua Grill
Verified email at
Cited by
Cited by
Targeting prodromal Alzheimer disease with avagacestat: a randomized clinical trial
V Coric, S Salloway, CH van Dyck, B Dubois, N Andreasen, M Brody, ...
JAMA neurology 72 (11), 1324-1333, 2015
Unmet needs of caregivers of individuals referred to a dementia care program
LA Jennings, DB Reuben, LC Evertson, KS Serrano, L Ercoli, J Grill, ...
Journal of the American Geriatrics Society 63 (2), 282-289, 2015
Transient analgesia evoked by noxious stimulus offset
JD Grill, RC Coghill
Journal of neurophysiology 87 (4), 2205-2208, 2002
Age-related and laminar-specific dendritic changes in the medial frontal cortex of the rat
JD Grill, DR Riddle
Brain research 937 (1-2), 8-21, 2002
Current therapeutic targets for the treatment of Alzheimer’s disease
JD Grill, JL Cummings
Expert review of neurotherapeutics 10 (5), 711-728, 2010
Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials
JD Grill, J Karlawish
Alzheimer's research & therapy 2 (6), 34, 2010
Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants
K Harkins, P Sankar, R Sperling, JD Grill, RC Green, KA Johnson, ...
Alzheimer's research & therapy 7 (1), 1-9, 2015
Facilitating Alzheimer’s disease research recruitment
JD Grill, JE Galvin
Alzheimer disease and associated disorders 28 (1), 1, 2014
Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative
JD Grill, L Di, PH Lu, C Lee, J Ringman, LG Apostolova, N Chow, ...
Neurobiology of aging 34 (1), 62-72, 2013
African Americans are less likely to enroll in preclinical Alzheimer's disease clinical trials
Y Zhou, D Elashoff, S Kremen, E Teng, J Karlawish, JD Grill
Alzheimer's & Dementia: Translational Research & Clinical Interventions 3 (1 …, 2017
Effect of study partner on the conduct of Alzheimer disease clinical trials
JD Grill, R Raman, K Ernstrom, P Aisen, J Karlawish
Neurology 80 (3), 282-288, 2013
Communicating mild cognitive impairment diagnoses with and without amyloid imaging
JD Grill, LG Apostolova, S Bullain, JM Burns, CG Cox, M Dick, D Hartley, ...
Alzheimer's research & therapy 9 (1), 35, 2017
Novel targets for Alzheimer's disease treatment
JD Grill, JL Cummings
Expert review of neurotherapeutics 10 (5), 711, 2010
Multilocus genetic profiling to empower drug trials and predict brain atrophy
O Kohannim, X Hua, P Rajagopalan, DP Hibar, N Jahanshad, JD Grill, ...
NeuroImage: Clinical 2, 827-835, 2013
Risk disclosure and preclinical Alzheimer’s disease clinical trial enrollment
JD Grill, J Karlawish, D Elashoff, BG Vickrey
Alzheimer's & Dementia 9 (3), 356-359. e1, 2013
Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials?
MS Cary, JD Rubright, JD Grill, J Karlawish
Alzheimer disease and associated disorders 29 (1), 70, 2015
Should we disclose amyloid imaging results to cognitively normal individuals?
JD Grill, DK Johnson, JM Burns
Neurodegenerative disease management 3 (1), 43-51, 2013
Critical review of the appropriate use criteria for amyloid imaging: effect on diagnosis and patient care
LG Apostolova, JM Haider, N Goukasian, GD Rabinovici, G Chételat, ...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 5, 15-22, 2016
Willingness to be a brain donor: a survey of research volunteers from four racial/ethnic groups
L Boise, L Hinton, HJ Rosen, M Ruhl, H Dodge, N Mattek, M Albert, ...
Alzheimer disease and associated disorders 31 (2), 135, 2017
Alzheimer’s disease progression by geographical region in a clinical trial setting
DB Henley, SA Dowsett, YF Chen, H Liu-Seifert, JD Grill, RS Doody, ...
Alzheimer's research & therapy 7 (1), 43, 2015
The system can't perform the operation now. Try again later.
Articles 1–20